Pearl River Capital’s Medtronic MDT Stock Holding History

Pearl River Capital’s Portfolio MDT Stock Details MDT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-121,092	Closed	-$9.53M	–	220
2024 Q2	$9.53M	Buy	+121,092	New	+$9.93M	1.51%	1
2024 Q1	–	Sell	-12,024	Closed	-$991K	–	604
2023 Q4	$991K	Buy	+12,024	New	+$916K	0.16%	205
2023 Q3	–	Sell	-25,370	Closed	-$2.24M	–	564
2023 Q2	$2.24M	Buy	+25,370	New	+$2.18M	0.36%	84
2022 Q4	–	Sell	-15,670	Closed	-$1.26M	–	551
2022 Q3	$1.26M	Buy	+15,670	New	+$1.41M	0.24%	137
2022 Q1	–	Sell	-35,750	Closed	-$3.7M	–	498
2021 Q4	$3.7M	Buy	35,750 +29,603	+482%	+$3.43M	1%	14
2021 Q3	$771K	Sell	6,147 -3,636	-37%	-$471K	0.21%	159
2021 Q2	$1.21M	Sell	9,783 -10,658	-52%	-$1.34M	0.33%	97
2021 Q1	$2.42M	Buy	20,441 +16,893	+476%	+$1.98M	0.77%	27
2020 Q4	$416K	Buy	+3,548	New	+$391K	0.15%	211
2020 Q1	–	Sell	-2,939	Closed	-$333K	–	630
2019 Q4	$333K	Buy	+2,939	New	+$323K	0.12%	303

Other funds holding MDT

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Pearl River Capital's MDT Position: Q3 2024 in Review

Pearl River Capital sold out of Medtronic (MDT) in Q3 2024, closing a stake of 121,092 shares — an estimated $9.53M sold.

Pearl River Capital first reported a position in MDT in Q4 2019 and held it in 10 quarters. The position peaked at $9.53M in Q2 2024. 2,063 funds tracked by Wall St. Rank hold MDT as of Q3 2024.

Pearl River Capital reported no remaining Medtronic position as of Q3 2024 after selling out during the quarter.
Pearl River Capital sold 121,092 Medtronic shares in Q3 2024, an estimated $9.53M.
Pearl River Capital first reported a position in Medtronic in Q4 2019 and held it in 10 quarters.
Pearl River Capital's Medtronic position peaked at $9.53M in Q2 2024.
2,063 funds tracked by Wall St. Rank held Medtronic as of Q3 2024.

Based on Pearl River Capital's 13F filing for Q3 2024.